| PDF (811kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-268473
- DOI to cite this document:
- 10.5283/epub.26847
Alternative links to fulltext:Pubmed
Abstract
The pharmacokinetics of midodrin (alpha-2,5-dimethoxyphenyl-beta-glycinamidoethanol hydrochloride, ST 1085) and its main metabolite ST 1059 (alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride) have been investigated in 12 male healthy volunteers. 2.5 mg midodrin hydrochloride were applied intravenously, as drinking solution or as tablet (Gutron) according to a randomized cross-over design. ...

Owner only: item control page